47
Participants
Start Date
August 31, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
February 28, 2011
VCL-IPM1
IM, 0.5 mg/mL, 2 injections, 0 and 21 days
VCL-IPM1
IM, 1 mg/mL, 2 injections, 0 and 21 days
VCL-IPT1
IM, 1 mg/mL, 2 injections, 0 and 21 days
PBS
IM, 1 mL, 2 injections, 0 and 21 days
SNBL, Baltimore
Accelovance, San Diego
SUNY at Stonybrook, Stony Brook Medical Center, Stony Brook
Lead Sponsor
Vical
INDUSTRY